Lung-MAP is a research study for people with a type of advanced lung cancer called non-small cell lung cancer (NSCLC). This study helps find the best treatment options by studying the cancer's genes, which are like special "markers" or "traits" that can affect how the cancer grows. Depending on the specific traits of a person's cancer, they will be assigned to a sub-study to test new treatments that aim to stop the cancer from growing or spreading. Some people whose cancer traits don't match any sub-study can still participate in other parts of the study.

• This study involves testing a piece of the cancer and a blood sample to see which sub-study is the best fit.
• Participants must be 18 or older and have advanced NSCLC, with prior treatments allowed.
• Consent is required to join, and there may be surveys and interviews for U.S. participants.

This study could help find new treatments for lung cancer, but participants need to be comfortable with the procedures and may need to give more samples if needed.